$1.97 -0.03 (%) Synta Pharmaceuticals Corp - NASDAQ

Sep. 1, 2015 | 02:24 PM

Partner Headlines

  1. Stocks Both Gurus and Company Insiders Are Buying

    GuruFocus | Jun. 18, 2015 | 12:49PM EST
  2. Netflix, Panera Bread Lead Wednesday's After-Hours Movers

    Benzinga | Apr. 15, 2015 | 19:07PM EST
  3. Insider Buys: FULL, FMI and SNTA

    GuruFocus | Apr. 10, 2015 | 22:43PM EST
  4. Weekly 3-Year Low Highlights: NSR, ELRC, PLPC, SNTA

    GuruFocus | Feb. 16, 2015 | 10:01AM EST
  5. 5-year lows: Vivus, Synta Pharmaceuticals Inc, MVC Capital Inc, and Kemet Corp.

    GuruFocus | Feb. 8, 2015 | 20:58PM EST
  6. 5-year lows: Synta Pharmaceuticals Inc, Rex Energy Corp, Petroquest Energy Inc, and Liquidity ...

    GuruFocus | Jan. 11, 2015 | 18:32PM EST
  7. 5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and ...

    GuruFocus | Dec. 28, 2014 | 17:09PM EST
  8. Synta Announces Presentation of Results from an Investigator-Sponsored Phase 1 Trial of Ganetespib in HER2+ Metastatic Breast Cancer

    Benzinga | Dec. 12, 2014 | 08:00AM EST
  9. InterMune's Roche Deal Sends Peer Group Up

    Benzinga | Aug. 25, 2014 | 11:38AM EST
  10. Synta Announces Advancement Of Ganetespib Into Phase 3 Extension Of AML LI-1 Study For Patients With AML And High-Risk MDS

    Benzinga | Jul. 21, 2014 | 16:30PM EST
  11. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga | Jun. 23, 2014 | 18:25PM EST
  12. 5-Star Biotech Stock Watch: Synta Pharmaceuticals

    Benzinga | Jun. 18, 2014 | 15:26PM EST
  13. 3 Biotech Stocks Backed By Big Money

    Benzinga | Jun. 16, 2014 | 14:27PM EST
  14. Morning Market Movers

    Benzinga | Mar. 20, 2014 | 09:39AM EST
  15. Benzinga's Top #PreMarket Gainers

    Benzinga | Mar. 20, 2014 | 08:08AM EST
  16. Top Trending Tickers On StockTwits For March 12

    Benzinga | Mar. 12, 2014 | 10:25AM EST
  17. Morning Movers for March 12th, 2014

    Benzinga | Mar. 12, 2014 | 10:15AM EST
  18. Morning Market Losers

    Benzinga | Mar. 12, 2014 | 09:49AM EST
  19. Benzinga's Top #PreMarket Losers

    Benzinga | Mar. 12, 2014 | 08:47AM EST
  20. UPDATE: Stifel Downgrades Synta Pharmaceuticals as GALAXY-2 Adjustments Further Diminish Likelihood For Success

    Benzinga | Mar. 12, 2014 | 08:13AM EST
  21. Earnings Scheduled For March 11, 2014

    Benzinga | Mar. 11, 2014 | 05:33AM EST
  22. Stocks Hitting 52-Week Lows

    Benzinga | Nov. 13, 2013 | 09:57AM EST
  23. Synta Pharmaceuticals Announces Proposed Public Offering of Common Stock

    Benzinga | Nov. 12, 2013 | 16:09PM EST
  24. Synta Presents Positive One-Year Follow-up Results for GALAXY-1 Trial of Ganetespib in NSCLC

    Benzinga | Oct. 26, 2013 | 10:12AM EST
  25. Synta Announces Encouraging Results of Ganetespib GALAXY-1 Trial at ECC 2013

    Benzinga | Sep. 28, 2013 | 09:26AM EST
  26. Shares of Synta Moving Higher Following News of Fast Track Designation for Ganetespib

    Benzinga | Sep. 12, 2013 | 08:27AM EST
  27. These Three Speculative Companies Are Loved By Insiders and Institutions

    Benzinga | Aug. 22, 2013 | 11:55AM EST
  28. Synta Provides Clinical Updates

    Benzinga | Aug. 1, 2013 | 06:51AM EST
  29. Synta Provides Clinical Updates

    Benzinga | Aug. 1, 2013 | 06:51AM EST
  30. Market Wrap for Monday, July 29: Stocks Record Moderate Losses to Start Trading Week

    Benzinga | Jul. 29, 2013 | 16:23PM EST
  31. Synta Pharmaceuticals Surges 45% on Positive ENCHANT-1 Breast Cancer Results

    Benzinga | Jul. 29, 2013 | 10:18AM EST
  32. Synta Announces ENCHANT-1 Breast Cancer Results Support Transition to Second Stage of Trial

    Benzinga | Jul. 29, 2013 | 07:11AM EST
  33. Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 10,000 Shares

    GuruFocus | Nov. 13, 2012 | 10:52AM EST
  34. Synta Pharmaceuticals, Inc. (SNTA) CEO Safi R Bahcall buys 10,000 Shares

    GuruFocus | Nov. 13, 2012 | 03:35AM EST
  35. Synta Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 6, 2012 | 04:35AM EST
  36. UPDATE: Jefferies Raises PT to $22 on Synta Pharmaceuticals on GALAXY Update

    Benzinga | Oct. 1, 2012 | 06:20AM EST
  37. UPDATE: Stifel Nicolaus Initiates Synta Pharmaceuticals at Hold; Enthusiasm Outpaces Expectations

    Benzinga | Aug. 30, 2012 | 07:02AM EST
  38. Synta Announces $25.8 Million Registered Direct Offering of Common Stock

    Benzinga | Jul. 26, 2012 | 01:34AM EST
  39. Weekly CEO Buys Highlight: SNTA, MEI, PZG, MCHX, CMXI

    GuruFocus | Jul. 7, 2012 | 17:43PM EST
  40. Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 10,000 Shares

    GuruFocus | Jul. 2, 2012 | 05:11AM EST
  41. Health Care Sector Wrap

    FoxBusiness | Jun. 28, 2012 | 10:47AM EST
  42. Synta Pharmaceuticals (SNTA) Up 15% after Jefferies Issues Bullish Note

    MarketIntelligenceCenter | Jun. 25, 2012 | 13:10PM EST
  43. UPDATE: Jefferies Raises PT on Synta from $7 to $14

    Benzinga | Jun. 25, 2012 | 08:33AM EST
  44. Teva Pharmaceutical Industries, Constellation Brands Among Stocks Up on High Volume Monday

    FoxBusiness | Jun. 25, 2012 | 06:33AM EST
  45. Quest Software, Pharmacyclics, Other Stocks Hit 52-Week Highs Monday

    FoxBusiness | Jun. 25, 2012 | 06:32AM EST
  46. Merck &, Onyx Pharmaceuticals Among Stocks Hitting 52-Week Highs Friday

    FoxBusiness | Jun. 22, 2012 | 06:33AM EST
  47. UPDATE: BMO Capital Markets Upgrades Synta Pharmaceuticals to Outperform on HSP90 Opportunity

    Benzinga | Jun. 4, 2012 | 08:45AM EST
  48. Benzinga's Top Pre-Market Losers

    Benzinga | Jun. 1, 2012 | 02:09AM EST
  49. Today's Top Small-Cap Winners!

    Benzinga | May. 31, 2012 | 10:18AM EST
  50. UPDATE: Jefferies Initiates Coverage on Synta Pharmaceuticals

    Benzinga | May. 22, 2012 | 03:20AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!